Pharmaco - Press Releases

Date	Title	Company
04-Aug-2021	Evotec SE to announce results for the first half-year 2021 on 11 August 2021	Evotec SE
04-Aug-2021	Artificial Cornea and Corneal Implant Market – Rising Prevalence of Diabetes and Related Eye Diseases to Support Growth	MarketsandMarkets Research Private Ltd.
04-Aug-2021	First half of 2021: Boehringer Ingelheim makes fundamental progress in research and development	Boehringer Ingelheim
04-Aug-2021	Gilead Sciences Endows Its Foundation With More Than $200 Million to Support Health Justice, Community Giving and Employee Match Program	Gilead Sciences
04-Aug-2021	The Most Widely Growth Strategies Adopted by Major Players Which are Advancing the Growth of Radiotherapy Market.	MarketsandMarkets Research Private Ltd.
04-Aug-2021	DEFENCE THERAPEUTICS SIGNS AN AGREEMENT WITH BIOPHARMA EXCELLENCE A PHARMALEX GMBH COMPANY, TO MAXIMIZE AND STRATEGIZE THE DEVELOPMENT OF ITS ACCUMTM PLATFORM AND CLINICAL TRIALS	Defence Therapeutics Inc.
03-Aug-2021	Polyphor provides final update on the Phase III FORTRESS study of balixafortide in patients with advanced HER2 negative breast cancer	Polyphor AG
03-Aug-2021	Spectricity Raises €14 Million Series B Funding as it Accelerates Plans to Deliver Industry Leading Hyperspectral Sensing to Mobile and Consumer Devices	Spectricity
03-Aug-2021	Advanced Clinical’s Graham Belgrave Named to the 2021 PharmaVOICE 100 List of Distinguished Leaders	Advanced Clinical
03-Aug-2021	Evonik acquires German biotech company JeNaCell to expand biomaterials portfolio for new medical device markets	Evonik
03-Aug-2021	F-star Therapeutics to Announce Second Quarter Results and Host Conference Call on August 12, 2021	F-star Therapeutics
03-Aug-2021	iTeos Therapeutics to Present at Wedbush PacGrow Healthcare Conference 2021	iTeos Therapeutics
03-Aug-2021	Bimekizumab becomes first treatment with positive recommendation through expedited NICE review process	UCB
03-Aug-2021	Nanoform and Boehringer Ingelheim execute master services agreement	Nanoform and Boehringer Ingelheim
03-Aug-2021	eTheRNA immunotherapies opens office in Hong Kong to support and build on its growing activities in China and broader Asia-Pacific	eTheRNA
03-Aug-2021	Sanofi to acquire Translate Bio; advances deployment of mRNA technology across vaccines and therapeutics development	Sanofi
03-Aug-2021	OPTIMA is back	Optima Group
03-Aug-2021	Alliance Healthcare Partners With Healthera To Bring Digital Revolution To Community Pharmacy	Alliance Healthcare
03-Aug-2021	Autolus and Moderna sign Option and License Agreement for access to proprietary targeting technology from Autolus	Autolus and Moderna
03-Aug-2021	OKYO Pharma Limited Announces final audited results for the year ended 31 March 2021	OKYO Pharma Limited